Loading...

Are We Sure that Adjuvant Chemotherapy is the Best Approach for Resectable Pancreatic Cancer? Are We in the Era of Neoadjuvant Treatment? A Review of Current Literature

The outcome of pancreatic cancer is poor, with a 9% 5-year survival rate. Current treatment recommendations in the 10%−20% of patients who present with resectable disease support upfront resection followed by adjuvant therapy. Until now, only early complete surgical (R0) resection and adju...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Ester Oneda, Alberto Zaniboni
Format: Artigo
Sprog:Inglês
Udgivet: MDPI AG 2019-11-01
Serier:Journal of Clinical Medicine
Fag:
Online adgang:https://www.mdpi.com/2077-0383/8/11/1922
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!